The Global Deep Venous Disease Treatment Devices Market Size is valued at 1.31 billion in 2023 and is predicted to reach 2.22 billion by the year 2031 at a 6.87% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
Vein-related illnesses are conditions that damage the body's veins. One of the most prevalent disorders brought on by harmed vessel walls and valves is varicose veins. According to an article in the Journal of the American Heart Association, around 23% of adults in the United States have varicose veins. Venous reflux disease is treated using a variety of techniques, including ablation, sclerotherapy injection, ligation or stripping, and supportive care.
The market is driven by elements such as the rise in deep vein disease incidence, which increases the demand for treatment devices. The rise in deep venous disease diagnoses in hospitals, which increases the need for preventative devices, and the rise in deep venous disease awareness drives the development of deep venous disease devices in the market.
However, producers and consumers have suffered due to the pandemic. The number of treatments substantially decreased since varicose vein surgeries are not urgent. A decrease also influenced the revenue streams of the manufacturers in varicose vein surgeries or procedures due to limitations on travel. Manufacturers are taking several strategic actions to recover from COVID-19. To enhance the technology and test findings associated with the pet food flavors and ingredients market, the players are engaging in several R&D activities, product launches, and strategic collaborations.
The Deep Venous, Disease Treatment Devices market, is segmented based on products and End-user. Product segment includes Thrombectomy and Thrombolysis Devices, Inferior Vena Cava (IVC) Filters, Peripheral Vascular Stents, PTA Balloon Catheters, Accessory Devices, and Compression Devices/Stockings. By End-User, the market is segmented into Hospitals and Clinics, Ambulatory Surgical Centers, and Homecare.
During the projected period, the growing elderly population and the rising prevalence of cardiovascular disorders are anticipated to be the key drivers of the accessory device segment's growth. Cardiovascular illnesses are more prone to strike the elderly population. Over 20.8% of the European population was 65 years or older, according to Ageing Europe Statistics, 2021. Between 2021 and 2100, it is predicted that the proportion of Europeans 80 years of age or older will rise from 6.0% to 14.6%, a two-and-a-half-fold increase. Additionally, the growing desire for minimally invasive procedures will probably fuel market expansion. For instance, a minimally invasive procedure called cardiac catheterization uses thin, elastic tubes called catheters to direct them via blood vessels to the problematic areas to identify and treat several heart and vascular disorders, including May-Thurner syndrome.
Due to a growth in hospitals and surgery centers, which was the largest contributor depending on end-user in 2023, is anticipated to keep up its dominance during the projected period. However, because ambulatory surgery centers are more affordable than traditional hospitals, this market segment is predicted to develop significantly during the forecast period.
North America held a share of revenue of approximately 45.0%, dominating the market in 2023. This is mostly caused by a sizable patient population that values appearance. Due to the obvious results and safety, many are eager to undergo cosmetic operations. The proof of the safety and effectiveness of laser therapy has contributed to lowering the stigma associated with cosmetic procedures and fostering societal acceptance of laser treatments, particularly among males. The region with the quickest growth is anticipated to be Asia Pacific. Due to its huge aging population, growing disposable money, and growing knowledge of these procedures, the Asia Pacific region is anticipated to have significant growth in the years to come. Because of the various legislative considerations that affect product availability between nations, the market is extremely diversified.
|
Report Attribute |
Specifications |
|
Market size value in 2023 |
USD 1.31 Bn |
|
Revenue forecast in 2031 |
USD 2.22Bn |
|
Growth rate CAGR |
CAGR of 6.87% from 2024 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Billion and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Products, End-user |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Abbott Laboratories, AndraTec GmbH, AngioDynamics, Inc., Boston Scientific Corporation, Cardinal Health, Cook Group, Innova Vascular, Inc., Koninklijke Philips N.V., Medtronic plc, Nipro Corporation, Penumbra, Inc., Stryker Corporation, Surmodics, Inc. (Vetex Medical Ltd.), Teleflex Incorporated, and Terumo Corporation. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Deep Venous Disease Treatment Devices Market Snapshot
Chapter 4. Global Deep Venous Disease Treatment Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product Type:
5.2.1. Thrombectomy and Thrombolysis Device
5.2.2. Inferior Vena Cava (IVC) Filter
5.2.3. Peripheral Vascular Stent
5.2.4. PTA Balloon Catheter
5.2.5. Accessory Device
5.2.6. Compression Device/Stockings
Chapter 6. Market Segmentation 2: by End-users Estimates & Trend Analysis
6.1. by End-users & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-users:
6.2.1. Hospitals and Clinics
6.2.2. Ambulatory Surgical Centres
6.2.3. Home-Care
Chapter 7. Deep Venous Disease Treatment Devices Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
7.1.2. North America Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.1.3. North America Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.2. Europe
7.2.1. Europe Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
7.2.2. Europe Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.2.3. Europe Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
7.3.2. Asia Pacific Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.3.3. Asia Pacific Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.4. Latin America
7.4.1. Latin America Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
7.4.2. Latin America Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.4.3. Latin America Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2023-2031
7.5.2. Middle East & Africa Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.5.3. Middle East & Africa Deep Venous Disease Treatment Devices Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Abbott Laboratories
8.2.2. AndraTec GmbH
8.2.3. AngioDynamics, Inc.
8.2.4. Boston Scientific Corporation
8.2.5. Cardinal Health
8.2.6. Cook Group
8.2.7. Innova Vascular, Inc.
8.2.8. Koninklijke Philips N.V.
8.2.9. Medtronic plc
8.2.10. Nipro Corporation
8.2.11. Penumbra, Inc.
8.2.12. Stryker Corporation
8.2.13. Surmodics, Inc. (Vetex Medical Ltd.)
8.2.14. Teleflex Incorporated
8.2.15. Terumo CorporationCardinal Health Inc.
8.2.16. Cordis Corp
8.2.17. Endologix Inc
8.2.18. Terumo Medical Corporation
8.2.19. Other Prominent Players
Deep Venous Disease Treatment Devices Market By Product-
Deep Venous Disease Treatment Devices Market By End User-
Deep Venous Disease Treatment Devices Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
